Vascular Interventions in Takayasu Arteritis

2024-7-23

(Levamisole Adulterated) Cocaine-Induced Vasculitis: What Is Known/Current Evidence

2024-7-23

Intravenous Immunoglobulins in Idiopathic Inflammatory Myopathies: Where Are We?

2024-1-10

Treatment of Myositis Associated With Immune Checkpoint Inhibitors

2023-11-2

Molecular Mechanisms Underlying Systemic Sclerosis–Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: an Update

2023-10-18

The Greater Trochanteric Pain Syndrome: Clinical Presentation, Diagnosis, and Management

2023-8-8

Mitochondrial DNA-Sensing Pathogen Recognition Receptors in Systemic Sclerosis-Associated Interstitial Lung Disease: a Review

2023-8-8

Systemic Sclerosis-Associated Myopathy: How to Treat

2023-7-19

Treatment of Immune-Mediated Necrotizing Myopathy

2023-7-13

Intra-articular Therapies for Knee Osteoarthritis: Current Update

2023-7-1

Patient Preferences and Osteoarthritis Care: What Do We Know About What Patients Want from Osteoarthritis Treatment?

2023-6-19

Exercise Therapy for Knee and Hip Osteoarthritis: Is There An Ideal Prescription?

2023-5-20

Painful Knee Osteoarthritis and Radiofrequency Neurotomy of Genicular Nerves

2023-5-15

The Contribution of the Psychologist in the Assessment and Treatment of Fibromyalgia

2023-4-13

Intra-articular Mineralization and Association with Osteoarthritis Development and Outcomes

2023-4-5

Pathogenesis and Treatment in IMNM

2023-3-22

Virtual Tools to Enable Management of Knee Osteoarthritis

2023-3-11

An Unusual Presentation of ANCA-Negative Granulomatosis With Polyangiitis (GPA) in the Gynecological Tract and Literature Review

2023-1-12

Management of Cancer-Associated Myositis

2022-10-21

Utility of Myositis-Specific Autoantibodies for Treatment Selection in Myositis

2022-9-28

Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

2022-9-24

Remote Management of Osteoporosis

2022-9-2

Tailored Interventions for Supporting Physical Activity Participation in People with Arthritis and Related Conditions: a Systematic Review

2022-8-20

Past, Present, and Future in Dermatomyositis Therapeutics

2022-7-26

Pros and Cons of Skeletal Medications in the COVID-19 Era

2022-7-16

Bisphosphonate Drug Holiday and Fracture Risk: Reviewing the Evidence

2022-7-6

The Effectiveness of Fracture Liaison Services in Improving Fragility Fracture Outcomes

2022-3-31

Understanding and Therapeutically Targeting the Scleroderma Myofibroblast

2022-3-1

Insights Into the Preclinical Models of SSc

2021-11-8

Acute Sacroiliac Joint Pain: Clinical Presentation, Causes, and Investigations

2021-11-8

Dysregulation of Type I Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?

2021-10-19

Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease

2021-9-28

Insights Into Systemic Sclerosis from Gene Expression Profiling

2021-8-20

Shoulder Pain — Where Are We Now?

2021-8-5

A Self-Report Multidimensional Health Assessment Questionnaire (MDHAQ) for Face-To-Face or Telemedicine Encounters to Assess Clinical Severity (RAPID3) and Screen for Fibromyalgia (FAST) and Depression (DEP)

2021-7-28

Inhibiting Interferon Pathways in Dermatomyositis: Rationale and Preliminary Evidence

2021-6-14

Consideration of Fibromyalgia in the Assessment and Treatment of SLE

2021-6-9

Adverse Events Associated with Belimumab Therapy in Systemic Lupus Erythematosus

2021-5-24

Clinical Trials in Myositis: Where Do We Stand?

2021-5-21

Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease

2021-5-8

Mechanisms and Mediators of Pain in Chronic Inflammatory Arthritis

2021-5-3

Update on Maintenance Therapies for ANCA-Associated Vasculitis

2021-4-29

Therapeutic Management of Immune-Mediated Necrotizing Myositis

2021-3-29

Updates in the Treatment of Rheumatoid Arthritis

2021-3-22

Quantity and Quality of Rheumatoid Arthritis and Osteoarthritis Clinical Practice Guidelines: Systematic Review and Assessment Using AGREE II

2021-2-26

Evaluation and Treatment of Pediatric Localized Scleroderma: Pearls and Updates

2021-2-13

Soluble Biomarkers for Prediction of Vascular and Gastrointestinal Disease Severity in Patients with Systemic Sclerosis

2021-2-11

In Pursuit of an Effective Treatment: the Past, Present and Future of Clinical Trials in Inclusion Body Myositis

2021-2-9

Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy

2021-2-6

Non-infectious Chronic Uveitis in Childhood: Assessment and Treatment in the Biological Era

2021-1-6